Monthly shots control HIV as well as pills in 2 big studies

SEATTLE (AP) — Two large international studies find monthly shots of HIV drugs worked as well as daily pills to control the virus that causes AIDS.

Drugmakers are seeking approval later this year in the United States and Europe. If approved, the shots would be a new option for people with HIV and could help some stay on treatment. Results were discussed Thursday at a conference in Seattle.

It’s unclear how must the injections would cost. Experts say that will affect who will be able to get the shots.

And there will be concerns about patients missing a monthly shot, which could lead to drug-resistant strains of the virus.

The shots are a long-acting combo of two HIV drugs — one made by Janssen, and one by ViiV Healthcare, which sponsored the research.

The Western Journal has not reviewed this Associated Press story prior to publication. Therefore, it may contain editorial bias or may in some other way not meet our normal editorial standards. It is provided to our readers as a service from The Western Journal.

Truth and Accuracy

Submit a Correction →



loading

We are committed to truth and accuracy in all of our journalism. Read our editorial standards.

Tags:
The Associated Press is an independent, not-for-profit news cooperative headquartered in New York City. Their teams in over 100 countries tell the world’s stories, from breaking news to investigative reporting. They provide content and services to help engage audiences worldwide, working with companies of all types, from broadcasters to brands.
The Associated Press was the first private sector organization in the U.S. to operate on a national scale. Over the past 170 years, they have been first to inform the world of many of history's most important moments, from the assassination of Abraham Lincoln and the bombing of Pearl Harbor to the fall of the Shah of Iran and the death of Pope John Paul.

Today, they operate in 263 locations in more than 100 countries relaying breaking news, covering war and conflict and producing enterprise reports that tell the world's stories.
Location
New York City




loading

Conversation